Clinical Trials on Esophageal Achalasia in Hong Kong

Total 75 results

Chinese University of Hong Kong

Recruiting

POEM + F for Achalasia - a Pilot Study

Achalasia

Hong Kong
Chinese University of Hong Kong

Unknown

Per-Oral Endoscopic Myotomy (P.O.E.M.) for Treatment of Primary Esophageal Motility Disorders

Achalasia

Hong Kong
Chinese University of Hong Kong

Completed

Per-Oral Endoscopic Myotomy (P.O.E.M.) for Treatment of Esophageal Motility Disorders (POEM)

Achalasia | Hypertensive LES

Hong Kong
Chinese University of Hong Kong

Unknown

Prospective Study on the Feasibility and Effectiveness of Per-Oral Endoscopic Myotomy (P.O.E.M.) for Treatment of Primary Esophageal Motility Disorders (POEM)

Primary Esophageal Motility Disorders Including Achalasia and Hypertensive LES

China
Chinese University of Hong Kong
Johns Hopkins University; Northwestern University Feinberg School of Medicine; Asian Institute of Gastroenterology, India and other collaborators

Not yet recruiting

POEM-F for Achalasia International Study

Achalasia

United States, China, Hong Kong, India
Chinese University of Hong Kong

Recruiting

The Microbiome of Oesophageal Squamous Cell Carcinoma

Esophageal Cancer | Microbial Colonization

Hong Kong
Hospital Authority, Hong Kong
The University of Hong Kong

Unknown

A Study of the Use of High-dose Proton Pump Inhibitor for the Treatment of Gastro-oesophageal Reflux Related Non-cardiac Chest Pain - a Randomized Double-blind Placebo-controlled Study

Chest Pain

China
Chinese University of Hong Kong

Recruiting

Antireflux Mucosectomy (ARMS) for Treatment of Gastroesophageal Reflux (ARMS)

Gastro Esophageal Reflux

Hong Kong
Chinese University of Hong Kong

Unknown

Translation and Validation of the PASS Test for GERD Patients With Partial Response to PPI: PASS-HK

Gastro-esophageal Reflux Disease

Hong Kong
Chinese University of Hong Kong

Recruiting

ARMA for Postoperative GERD After Sleeve Gastrectomy

Gastroesophageal Reflux

Hong Kong
Chinese University of Hong Kong

Recruiting

Effect of Routine Anterior Crural Repair in De-Novo Gastroesophageal Reflux After Laparoscopic Sleeve Gastrectomy

Obesity | Gastro Esophageal Reflux Disease

China
Chinese University of Hong Kong

Completed

Multi-Center Prospective Randomized Trial Comparing Standard Esophagectomy Against Chemo-Radiotherapy for Treatment of Squamous Esophageal Cancer - Early Results From the Chinese University Research Group for Esophageal Cancer (CURE)

Esophageal Cancer

China
Chinese University of Hong Kong

Completed

BRAVO Study for Functional Dyspepsia (BD)

Dyspepsia | Gastroesophageal Reflux

Hong Kong
Hospital Authority, Hong Kong
The University of Hong Kong

Unknown

The Use of Proton Pump Inhibitor for the Treatment of Non-erosive Gastro-oesophageal Reflux Disease in Chinese Population

Gastroesophageal Reflux

China
Chinese University of Hong Kong

Unknown

A Prospective Randomized Trial Comparing Laparoscopic Nissen Against Anterior Partial Fundoplication in Treating Gastroesophageal Reflux Disease Among Chinese Patients

Gastroesophageal Reflux Disease

Hong Kong
Chinese University of Hong Kong

Recruiting

Long Term Incidence and Effect of de Novo GERD After Laparoscopic Sleeve Gastrectomy in Chinese Population

Gastroesophageal Reflux

Hong Kong
Muhammad

Not yet recruiting

Effect of Lidocaine Block on Gastroesophageal Reflux Disease

Gastroesophageal Reflux Disease

Hong Kong
Chinese University of Hong Kong

Completed

Functional Gastrointestinal Disorder Screening Program - A Randomized Controlled Trial (FGISP-RCT)

Functional Dyspepsia | Irritable Bowel Syndrome | Non-erosive Gastroesophageal Reflux Disease

Hong Kong
Chinese University of Hong Kong

Terminated

The Role of Visceral Hyperalgesia, Gastroesophageal Reflux Disease (GERD) and Esophageal Motility Disorder (EMD) in NCCP Patients

Non-Cardiac Chest Pain

China
The University of Hong Kong
Haven of Hope Hospital; The Social Innovation and Entrepreneurship Development...

Completed

Dysphagia Cups in Elderly and Rehabilitation Setting

Technology

Hong Kong
Chinese University of Hong Kong

Completed

Development of a Novel Disease-Specific Quality of Life Questionnaire for Gastroesophageal Reflux Disease (GERD) Patients in Chinese Population

Gastroesophageal Reflux Disease

China
Hospital Authority, Hong Kong
The University of Hong Kong

Completed

Prospective Double-blinded Randomized Controlled Trial of 12-weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese Patients

Gastroesophageal Reflux | Laryngitis

China
Chinese University of Hong Kong

Completed

Symptomatic Gastroesophageal Reflux Disease: Double Blind Randomized Controlled Study of On-demand Therapy Versus Maintenance Therapy

Gastroesophageal Reflux Disease

China
Chinese University of Hong Kong

Terminated

Drug to Prevent Pneumonia in the Tube Fed

Pneumonia | Neurological Dysphagia

Hong Kong
Zeng Changhao

Recruiting

Multifunctional Nutrition Tube in Dysphagia for Nasopharyngeal Carcinoma

Dysphagia

Hong Kong
Shanghai Chest Hospital
Chang Gung Memorial Hospital; Tianjin Medical University Cancer Institute and... and other collaborators

Unknown

Pre-Surgery If Needed for Oesophageal Cancer (preSINO)

Esophageal Cancer

China, Hong Kong, Taiwan
Chinese University of Hong Kong

Completed

The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal Cancer (AP)

Squamous Cell Carcinoma of Esophagus

China
Chinese University of Hong Kong

Completed

Minimally Invasive Evaluation of Dyspepsia by Combined Magnetically Controlled Capsule Endoscopy and Urea Breath Test: a Pilot Prospective Cohort Study (MCUDYSPEPSIA)

Dyspepsia | Gastroesophageal Reflux | Peptic Ulcer Disease | Pancreatobiliary Disease | Ugi Malignancies

Hong Kong
Arbele Pty Ltd

Recruiting

Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients

Gastric Cancer | Pancreatic Cancer | Cholangiocarcinoma | Esophageal Adenocarcinoma | Gastrointestinal Cancer | Liver Cancer | Colorectal Adenocarcinoma | Gastroesophageal Junction

Hong Kong, Australia
Chinese University of Hong Kong

Active, not recruiting

EUS Guided Cyanoacrylate Injection vs Endoscopic Variceal Band Ligation for Prevention of Rebleeding in Patients With Hepatocellular Carcinoma and Esophageal Variceal Bleeding (EUSgluevsVBL)

EUS Guided Cyanoacrylate Injection | Endoscopic Variceal Band Ligation | Hepatocelular Carcinoma | Esophageal Variceal Bleeding

Hong Kong
Takeda

Completed

Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease

Gastroesophageal Reflux Disease

Hong Kong, Korea, Republic of, Taiwan
Novartis Pharmaceuticals

Completed

Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)

Esophageal Squamous Cell Carcinoma

Taiwan, Spain, Canada, Singapore, Hong Kong, Korea, Republic of, Belgium, United Kingdom, United States
AstraZeneca

Completed

Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment.

Gastroesophageal Reflux Disease

Vietnam
Novartis Pharmaceuticals

Terminated

Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies

Colorectal Cancer | Gastrointestinal Stromal Tumors | Non-small Cell Lung Carcinoma | Head and Neck Squamous Cell Carcinoma | Esophageal SCC

United States, Germany, Spain, Singapore, Australia, Hong Kong, Belgium, Japan, China
Sidney Kimmel Comprehensive Cancer Center at Johns...

Withdrawn

Head and Neck Cancer Treatment Related Dysphagia

Head and Neck Cancer | Dysphagia

United States, China, Australia, Canada
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Distribution of Lymph Node Metastases in Esophageal Carcinoma (TIGER)

Esophageal Neoplasms | Lymph Node Metastases

Netherlands, United States, Italy, Spain, Sweden, Brazil, Canada, China, Finland, Germany, Greece, Hong Kong, India, Japan
Zhujiang Hospital
Guangdong Xiangxue Precision Medical Technology Co., Ltd.; Xiangxue Life Science... and other collaborators

Completed

To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors

Solid Tumor | Breast Cancer Stage IV | Gastric Cancer Stage IV | Ovarian Cancer Stage IV | Liver Cancer Stage IV | Esophageal Cancer, Stage IV | Bone and Soft Tissue Tumors | Bladder Carcinoma Stage IV | Prostate Carcinoma Stage IV | Thyroid Cancer Stage IV

China
Daiichi Sankyo, Inc.

Completed

DX-8951f in Treating Patients With Metastatic Stomach Cancer

Gastric Cancer | Esophageal Cancer

United States, Canada
Translational Oncology Research International
National Cancer Institute (NCI); University of California, Los Angeles

Completed

Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer

Gastric Cancer | Esophageal Cancer

United States
Bristol-Myers Squibb

Completed

An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy

Locally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal Junction

France, Poland, Russian Federation, Taiwan, United States, Hong Kong, Spain, Germany, Italy, Japan, Korea, Republic of, Singapore
Hoffmann-La Roche

Active, not recruiting

A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma (SKYSCRAPER-08)

Esophageal Cancer

Korea, Republic of, China, Hong Kong, Thailand, Taiwan
Jonsson Comprehensive Cancer Center
Pharmacia and Upjohn

Completed

Irinotecan in Treating Patients With Esophageal or Stomach Cancer

Gastric Cancer | Esophageal Cancer

United States
VA Office of Research and Development

Completed

A Randomized Trial of Medical and Surgical Treatments for Patients With GERD Symptoms That Are Refractory to Proton Pump Inhibitors

GERD

United States
AstraZeneca

Completed

ASTERIX: Low Dose ASA and Nexium

Gastroesophageal Reflux

Bulgaria, Italy, South Africa, Spain, Hungary, Canada, Hong Kong, Greece, Germany, Australia, United Kingdom
Merck Sharp & Dohme LLC

Active, not recruiting

Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

Esophageal Squamous Cell Carcinoma (ESCC) | Gastroesophageal Junction Carcinoma (GEJC) | Esophageal Adenocarcinoma (EAC)

China, Canada, United States, Argentina, Belgium, Brazil, Chile, Czechia, Denmark, Estonia, France, Germany, Guatemala, Hong Kong, Hungary, Italy, Japan, Korea, Republic of, Mexico, Peru, Philippines, Portugal, Romania, Russian Federation and more
Janssen Research & Development, LLC
Eisai Inc.

Completed

A Study of Single and Multiple Doses of Rabeprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive

Gastroesophageal Reflux Disease (GERD)

United States, Poland, United Kingdom, Belgium, Brazil
Merck Sharp & Dohme LLC

Completed

First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590)

Esophageal Neoplasms

Taiwan, China, United States, Argentina, Australia, Brazil, Canada, Chile, Colombia, Costa Rica, Denmark, France, Germany, Guatemala, Hong Kong, Japan, Korea, Republic of, Malaysia, Peru, Romania, Russian Federation, South Africa, S... and more
Radiation Therapy Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach

Gastric Cancer | Esophageal Cancer

United States
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Completed

Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Esophageal Cancer

United States
Merck Sharp & Dohme LLC
Eisai Inc.

Recruiting

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014)

Metastatic Esophageal Squamous Cell Carcinoma

Argentina, Chile, United States, Canada, China, Costa Rica, Denmark, France, Guatemala, Hong Kong, Hungary, Italy, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Turkey, United Kingdom, Romania, Ukraine, Singapore, Ma... and more

Clinical Trials on Esophageal Achalasia in Hong Kong

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations